OR2-4: Exogenous administration of protease-resistant, non matrixbinding IGFBP-2 inhibits tumour growth in a murine model of breast cancer
Soh, C.-L., McNeil, K., Owczarek, C.M., Hardy, M., Fabri, L.J., Pearse, M., Delaine, C.A., Forbes, B.E.Volume:
24
Language:
english
Journal:
Growth Hormone & IGF Research
DOI:
10.1016/S1096-6374(14)50020-2
Date:
October, 2014
File:
PDF, 437 KB
english, 2014